- Home
- FAMI vs PALI Comparison
FAMI vs PALI Comparison
Compare FAMI & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FAMI
- PALI
- Stock Information
- Founded
- FAMI 2015
- PALI 1996
- Country
- FAMI China
- PALI United States
- Employees
- FAMI N/A
- PALI N/A
- Industry
- FAMI Packaged Foods
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FAMI Consumer Staples
- PALI Health Care
- Exchange
- FAMI Nasdaq
- PALI Nasdaq
- Market Cap
- FAMI 3.4M
- PALI 3.5M
- IPO Year
- FAMI 2018
- PALI N/A
- Fundamental
- Price
- FAMI $0.28
- PALI $2.44
- Analyst Decision
- FAMI
- PALI Strong Buy
- Analyst Count
- FAMI 0
- PALI 1
- Target Price
- FAMI N/A
- PALI $8.00
- AVG Volume (30 Days)
- FAMI 544.2K
- PALI 187.7K
- Earning Date
- FAMI 11-29-2024
- PALI 11-12-2024
- Dividend Yield
- FAMI N/A
- PALI N/A
- EPS Growth
- FAMI N/A
- PALI N/A
- EPS
- FAMI 0.13
- PALI N/A
- Revenue
- FAMI $86,261,500.00
- PALI N/A
- Revenue This Year
- FAMI N/A
- PALI N/A
- Revenue Next Year
- FAMI N/A
- PALI N/A
- P/E Ratio
- FAMI $2.28
- PALI N/A
- Revenue Growth
- FAMI N/A
- PALI N/A
- 52 Week Low
- FAMI $0.17
- PALI $2.18
- 52 Week High
- FAMI $2.35
- PALI $22.35
- Technical
- Relative Strength Index (RSI)
- FAMI 46.10
- PALI 37.25
- Support Level
- FAMI $0.28
- PALI $2.33
- Resistance Level
- FAMI $0.32
- PALI $2.89
- Average True Range (ATR)
- FAMI 0.03
- PALI 0.30
- MACD
- FAMI -0.00
- PALI 0.01
- Stochastic Oscillator
- FAMI 44.44
- PALI 23.53
About FAMI Farmmi Inc.
Farmmi Inc is a supplier of agricultural products. The products of the company are Shiitake Mushroom, Mu Er Mushroom and other edible fungi and other agricultural products. The majority of products are sold in mainland China.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.